Glucose Testing

The field for glucose testing devices is crowded; worldwide, more than 50 companies market blood glucose monitors. The extraordinary market growth fueled by the increasing numbers of diagnosed diabetics continues to attract more entrants to the industry. Glucose self-testing has, therefore, attracted a varied cast of players including: large multinational companies such as Abbott Laboratories, Bayer Corp., LifeScan/Johnson & Johnson, and Roche Diagnostics; insulin pump companies Medtronic/MiniMed, Disetronic; and Animas and smaller device companies such as Home Diagnostics and Sontra Medical Inc.

The report offers a quantitative assessment of specific markets, worldwide, in US dollars for 2005 to 2015. The report's goals are:

> to report on the most recent developments in glucose testing,

> to provide a review of new diagnostic devices that are expected to come to market in the next 5-15 years,

> to present a look at the market impact of new diagnostic devices in and about 2010.

In the area of market analysis, this report provides information on companies and technologies currently on the market and those that challenge the status quo of blood glucose testing.

The report concentrates on an analysis of the market for glucose testing monitors and devices:

Glucose Meters, Traditional

Glucose Meters, Painless / Alternate Site

Non-Invasive Devices

Continuous Testing Devices

The information found in this report is based on data culled from the Kalorama Information’s In Vitro Diagnostic Database and assembled into a narrative by Kalorama analysts. The database is updated daily, and includes:

Published content from Kalorama Information’s catalog

Company issued press releases

Company web sites and Annual reports

Syndicated news services

Industry news and technology sources

Personal communications from industry contacts

May 8, 2006, 74 Pages, PDF
Table of Contents
Price: $2,495.00 / GBP1,247.50